ArticleJournal of thoracic disease2026
Clinical classification of chronic obstructive pulmonary disease with invasive pulmonary aspergillosis: a retrospective study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulmonary artery involvement contributes to the recurrence of hemoptysis after bronchial artery embolization in patients with chronic pulmonary aspergillosis.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with chronic obstructive pulmonary disease (COPD) complicated by invasive pulmonary aspergillosis (IPA) have high mortality and significant clinical heterogeneity. However, systematic classification criteria are currently lacking. To address this, our study proposes a clinical classification system specifically for COPD-IPA, based on its distinct clinical manifestations and pulmonary imaging features. Methods: We performed a retrospective analysis of clinical and radiological features in patients diagnosed with COPD-IPA during hospitalization from 2008 to 2024 to develop a novel clinical classification system. Demographic characteristics, laboratory parameters, radiologic manifestations, and prognosis were compared across the identified subtypes. Results: The study cohort comprised 63 COPD-IPA patients, who were predominantly elderly males (mean age: 70.9±8.7 years; 95.2% male). A novel classification system defined five distinct subtypes: (I) the fulminant type (3/63, 4.8%), which progressed rapidly to respiratory failure [partial pressure of arterial oxygen (PaO Conclusions: The five-subtype classification system established in this study delineates the heterogeneity of COPD-IPA and provides a novel framework to guide precise clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.